Yahoo Web Search

Search results

1. www.marketwatch.com › investing › stockIMGN Stock Price | Immunogen Inc. Stock Quote (U.S.: Nasdaq ...

   www.marketwatch.com › investing › stock

   Feb 9, 2024 · Immunogen Inc. (IMGN) is a biotechnology company that develops antibody-based therapies for cancer and autoimmune diseases. The stock price, performance, analyst ratings, news, and events of IMGN are shown on MarketWatch.

   • 1 Month: 4.94%
   • 5 Day: 6.73%

   • 3 Month: 111.59%
   • YTD: 5.33%

2. finance.yahoo.com › quote › IMGNWill be right back... - Yahoo Finance - Stock Market Live ...

   finance.yahoo.com › quote › IMGN

   VDOM DHTML tml>. Yahoo. Will be right back... Thank you for your patience.

3. www.investors.com › news › technologyIMGN Stock: AbbVie To Buy ImmunoGen In $10.1 Billion Cash ...

   www.investors.com › news › technology

   • Cached

   AbbVie (ABBV) will acquire ImmunoGen (IMGN), a biotech firm that makes ovarian cancer drug Elahere, in a cash deal. IMGN stock jumped 82.8% on the news, while ABBV stock rose 2.8%.

4. www.marketbeat.com › stocks › NASDAQImmunoGen (IMGN) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   2 days ago · 12 Wall Street analysts have issued twelve-month target prices for ImmunoGen's stock. Their IMGN share price targets range from $16.00 to $31.26. On average, they anticipate the company's share price to reach $25.77 in the next year. This suggests that the stock has a possible downside of 17.5%.

   • 0.9/5

   • Email: courtney.okonek@immunogen.com

5. www.fool.com › quote › nasdaqImmunoGen - IMGN - Stock Price & News | The Motley Fool

   www.fool.com › quote › nasdaq

   • Cached

   ImmunoGen is a biotech company that develops antibody-drug conjugates for cancer treatment. See its current and historical stock price, financial data, news articles, and industry comparison.

   • Works For: Immunogen

6. investor.immunogen.comInvestors | ImmunoGen, Inc.

   investor.immunogen.com

   • Cached

   Feb 12, 2024 · ImmunoGen is a biotechnology company developing antibody-drug conjugates (ADCs) for cancer patients. It was acquired by AbbVie in February 2024 and its stock is no longer traded on Nasdaq.

7. People also ask

   What are IMGN share price targets?

   • Their IMGN share price targets range from $16.00 to $31.26. On average, they anticipate the company's share price to reach $25.77 in the next twelve months. This suggests that the stock has a possible downside of 17.5%. View analysts price targets for IMGN or view top-rated stocks among Wall Street analysts.

   ImmunoGen (IMGN) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/IMGN/

   See all results for this question

   Where is IMGN headquartered?

   • Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. IMGN | Complete Immunogen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

   IMGN Stock Price | Immunogen Inc. Stock Quote (U.S.: Nasdaq

   www.marketwatch.com/investing/stock/imgn

   See all results for this question

   Why did IMGN stock soared after AbbVie bought immunogen?

   • IMGN stock soared after AbbVie agreed to buy ImmunoGen for $10.1 billion, offering a rich premium for the maker of cancer drug Elahere.

   IMGN Stock: AbbVie To Buy ImmunoGen In $10.1 Billion Cash Deal

   www.investors.com/news/technology/imgn-stock-abbv-stock-biotech-acquisition-elahere/

   See all results for this question

   Should investors hold IMGN shares?

   • There are currently 9 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" IMGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMGN, but not buy additional shares or sell existing shares.

   ImmunoGen (IMGN) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/IMGN/

   See all results for this question

8. markets.businessinsider.com › stocks › imgn-stockImmunoGen Stock Price | IMGN Stock Quote, News, and History ...

   markets.businessinsider.com › stocks › imgn-stock

   • Cached

   ImmunoGen Inc. (IMGN) is a biotechnology company that develops antibody-drug conjugates for cancer treatment. See the latest stock quote, news, analyst ratings, earnings, and insider activity for IMGN.